Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005502 · ClinicalTrials.gov registry record
Coronary Disease Morbidity and Mortality in a Population
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 5,476
- Enrollment target
NCT00005502: Completed study, sponsored by Mayo Clinic.
NCT00005502 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 5,476 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005502 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 5,476 participants
- Enrollment target
Study Summary
To study the entire population of Olmsted County, Minnesota, including all age categories, to examine the secular trends in coronary heart disease (CHD) mortality, myocardial infarction (MI) incidence, and natural history, including MI severity, case fatality and post-MI morbidity. Also, to examine the time trends in the prevalence of CHD at post-mortem because of the uniquely high autopsy rate in Olmsted County.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,476 participants |
| Start Date | 2002-10 |
| Est. Completion | 2013-04 |
What the finished NCT00005502 record still lists
NCT00005502 is an observational study that tracks outcomes without assigning an intervention. Its 5,476 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00005502 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005502 about?
NCT00005502 is a clinical study titled "Coronary Disease Morbidity and Mortality in a Population". To study the entire population of Olmsted County, Minnesota, including all age categories, to examine the secular trends in coronary heart disease (CHD) mortality, myocardial infarction (MI) incidence, and natural history, including MI severity, case fatality and post-MI morbidity. Also, to examine ...
What is the current status of trial NCT00005502?
This trial is currently completed. The enrollment target is 5,476 participants. The study started on 2002-10. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT00005502?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia